Coronary Artery Disease and Myocardial Infarction

CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Kausik Ray, , , et al

Watch time: 95m (4 videos)
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s

Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al

Hans-Willi Breuer ,

Remo Albiero ,

Astrid Hubert , Andreas Seitz , Valeria Martínez Pereyra , et al

Kevin Cheng , Paul Sainsbury , Michael Fisher , et al

Yukiko Isekame , Sabiha Gati , Jose Antonio Aragon-Martin , et al

Alberto Lorenzatti , Peter P Toth ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Julia Sikorska , James Uprichard ,

Kausik Ray, , , et al

Watch time: 95m (4 videos)

Kerry Layne , Albert Ferro ,

Media

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Yassir Javaid, , , et al

Watch time: 1h 6m (4 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

Media

CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Kausik Ray, , , et al

Watch time: 95m (4 videos)
AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46:28
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Yassir Javaid, , , et al

Watch time: 1h 6m (4 videos)
EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx

Giuseppe Tarantini,

4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Erin D Michos,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events

Paul M Ridker,

ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a)

Steven E Nissen,

ACC 22: Results from the TRANSLATE-TIMI 70 Trial

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

EuroPCR 21: The EBC Main Study

David Hildick-Smith,

ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

ESC 2020: APOC-III Reduction in Cardiovascular Disease

Jean-Claude Tardif,

View From The Thoraxcenter: What's Hot at ESC 2020

Nicolas M Van Mieghem, Joost Daemen,

ESC 2019 - Changes to ESC Guidelines for High-Risk Pulmonary Embolism Patients

Nicolas Meneveau,

Articles

Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Maya Rosana Amalia

,

Susi Herminingsih

,

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e61.

DOI:

https://doi.org/10.15420/ecr.2021.16.PO5
  • Views: Views 327
  • Downloads: Downloads 13

APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh

,

Brian Ference

,

Stephen J Nicholls

,

Ann Marie Navar

,

Derek P Chew

,

Karam M Kostner

,

Ben He

,

Hung-Fat Tse

,

Jamshed J Dalal

,

Anwar Santoso

,

Junya Ako

,

Hayato Tada

,

Jin Joo Park

,

Mei Lin Ong

,

Eric Lim

,

Tavin Subramaniam

,

Yi-Heng Li

,

Arintaya Phrommintikul

,

SS Iyengar

,

Saumitra Ray

,

Kyung Woo Park

,

Hong Chang Tan

,

Narathip Chunhamaneewat

,

Khung Keong Yeo

,

Jack Wei Chieh Tan

,

Published:

09 December 2021

Citation:

European Cardiology Review 2021;16:e54.

DOI:

https://doi.org/10.15420/ecr.2021.36
  • Views: Views 1421
  • Downloads: Downloads 127
  • Citations: 2

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap

Aarti Thakkar

,

Anandita Agarwala

,

Erin D Michos

,

Published:

08 November 2021

Citation:

European Cardiology Review 2021;16:e41.

DOI:

https://doi.org/10.15420/ecr.2021.24
  • Views: Views 2016
  • Downloads: Downloads 102
  • Citations: 3

ISCHEMIA Trial: Key Questions and Answers

José López-Sendón

,

Raul Moreno

,

Juan Tamargo

,

Published:

14 September 2021

Citation:

European Cardiology Review 2021;16:e34.

DOI:

https://doi.org/10.15420/ecr.2021.16
  • Views: Views 4301
  • Downloads: Downloads 252
  • Citations: 1